Bladder cancer surgeons, Drs Cheryl Lee and Khurshid Guru are inspired by a recent Swedish study and discuss aggregate surgical outcomes data comparing their different surgical approaches.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970411). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Guidelines for Perioperative Care After Radical Cystectomy for Bladder Cancer: Enhanced Recovery After Surgery (ERAS®) Society Recommendations https://www.clinicalnutritionjournal.com/article/S0261-5614(13)00254-9/fulltext

Association Between Smoking and Risk of Bladder Cancer Among Men and Women https://jamanetwork.com/journals/jama/fullarticle/1104233/

Robotics in Urology: No More Shadows? https://www.mdpi.com/2673-4397/1/4/28/htm/

Prognostic Impact of Comorbidity in Patients With Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262100/

Drs Cheryl Lee and Matthew Galsky superbly synthesize the latest critical elements for sequencing perioperative bladder cancer therapies.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970412). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Multimodal Management of Muscle Invasive Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190161/

Role of Immunotherapy in Localized Muscle Invasive Urothelial Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795541/

Drs Cheryl Lee and Peter Black share exciting new ways to use liquid biopsy ctDNA testing for bladder cancer diagnostics and patient monitoring.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970413). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Adjuvant Atezolizumab Versus Observation in Muscle-Invasive Urothelial Carcinoma (Imvigor010): A Multicentre, Open-Label, Randomised, Phase 3 Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495594/

ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma https://www.nature.com/articles/s41586-021-03642-9

ClinicalTrials.gov: Treatment of Metastatic Bladder Cancer at the Time of Biochemical reLApse Following Radical Cystectomy (TOMBOLA) https://clinicaltrials.gov/ct2/show/NCT04138628